The Journal of Contemporary Dental Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  25 (2024)
Volume  24 (2023)
Volume  23 (2022)
Volume  22 (2021)
Volume  21 (2020)
Volume  20 (2019)
Volume  19 (2018)
Volume  18 (2017)
Volume  17 (2016)
Volume  16 (2015)
Volume  15 (2014)
Volume  14 (2013)
Volume  13 (2012)
Volume  12 (2011)
Volume  11 (2010)
Volume  10 (2009)
Volume  9 (2008)
Volume  8 (2007)
Volume  7 (2006)
Volume  6 (2005)
Volume  5 (2004)
Volume  4 (2003)
Volume  3 (2002)
Volume  2 (2001)
Volume  1 (1999)
Related articles

VOLUME 17 , ISSUE 6 ( June, 2016 ) > List of Articles

REVIEW ARTICLE

Oral Cancer-related Inherited Cancer Syndromes: A Comprehensive Review

Akshit Batra, Sujata Yerawadekar

Citation Information : Batra A, Yerawadekar S. Oral Cancer-related Inherited Cancer Syndromes: A Comprehensive Review. J Contemp Dent Pract 2016; 17 (6):504-510.

DOI: 10.5005/jp-journals-10024-1880

Published Online: 01-11-2016

Copyright Statement:  Copyright © 2016; The Author(s).


Abstract

How to cite this article

Sarode GS, Batra A, Sarode SC, Yerawadekar S, Patil S. Oral Cancer-related Inherited Cancer Syndromes: A Comprehensive Review. J Contemp Dent Pract 2016;17(6):504-510.

PDF Share
  1. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 2008 Sep;25(9):2097-2116.
  2. Pathogenesis of hereditary tumors: beyond the “two-hit” hypothesis. Clin Genet 2002 Nov;62(5):345-357.
  3. Mechanisms of inherited cancer susceptibility. J Zhejiang Univ Sci B 2008 Jan;9(1):1-4.
  4. A new theory on cancer-inducing mechanism. Br J Cancer 1953 Mar;7(1):68-72.
  5. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br J Cancer 1957 Jun;11(2):161-169.
  6. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971 Apr;68(4):820-823.
  7. A new classification of potentially malignant disorders of the oral cavity. Oral Oncol 2011 Sep;47(9):920-921.
  8. Oral potentially malignant disorders: a proposal for terminology and definition with review of literature. J Oral Maxillofac Pathol 2014 Sep;18(Suppl 1):S77-S80.
  9. Oral (mucosal) potentially malignant disorders. Oral Oncol 2012 Oct;48(10):e35-e36.
  10. Oral squamous cell carcinoma prone disorders/individuals. Oral Oncol 2015 Jan;51(1):e4.
  11. Oral potentially malignant disorders: precising the definition. Oral Oncol 2012 Sep;48(9):759-760.
  12. Sur un syndrome progressif cormprenant des télangiectasies capillaires cutanées et conjonctivales symétriques, à disposition naevoïde et des troubles cérébelleux. Confinia Neurol 1941;4:32-42.
  13. Ataxia-telangiectasia: an overview. In: Gatti RA, Swift M, editors. Ataxia-telangiectasia: genetics, neuropathy, and immunology of a degenerative disease of childhood. Vol. 9. Kroc Foundation Series. New York (NY): Alan R. Liss; 1985. p. 1-63.
  14. The neurological phenotype of ataxia-telangiectasia: solving a persistent puzzle. DNA Repair (Amst) 2008 Jul;7(7):1028-1038.
  15. Ataxia-telangiectasia: an evolving phenotype. DNA Repair (Amst) 2004 Aug-Sep;3(8-9):1187-1196.
  16. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995 Jul 23;268(5218):1749-1753.
  17. Ataxia telangiectasia. Semin Pediatr Neurol 1998 Dec;5(4):287-294.
  18. Quantitative neurologic assessment of ataxia-telangiectasia. Neurology 2000 Apr;54(7):1505-1509.
  19. Consequences of the delayed diagnosis of ataxia-telangiectasia. Pediatrics 1998 Jul;102(1 Pt 1):98-100.
  20. Cutaneous granulomatous lesions in patients with ataxia-telangiectasia. J Pediatr 1991 Dec;119(6):917-922.
  21. Immunodeficiency and infections in ataxiatelangiectasia. J Pediatr 2004 Apr;144(4):505-511.
  22. Lymphoid tumors and breast cancer in ataxia telangiectasia: substantial protective effect of residual ATM kinase activity against childhood tumors. British J Cancer 2011 Aug 9;105(4):586-591.
  23. Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 2005 Jun 1;97(11):813-822.
  24. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 2006 Aug;38(8):873-875.
  25. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature 1988 Dec 8;336(6199):577-580.
  26. ATM: genome stability, neuronal development, and cancer cross paths. Adv Cancer Res 2001;83:209-254.
  27. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 2005 Jan 1;33(Database issue):D514-D517.
  28. Andrews’ diseases of the skin: clinical dermatology. 10th ed. Philadelphia (PA): Saunders;2005. p. 575.
  29. Regulation and localization of the bloom syndrome protein in response to DNA damage. J Cell Biol 2001 Apr 16;153(2):367-380.
  30. Congenital telangiectatic erythema resembling lupus erythematosus in dwarfs: probably a syndrome entity. AMA Am J Dis Child 1954 Dec;88(6):754-758.
  31. Carrier frequency of the Bloom syndrome blmAsh mutation in the Ashkenazi Jewish population. Mol Genet Metab 1998 Aug;64(4):286-290.
  32. Bloom syndrome: a Mendelian prototype of somatic mutational disease. Medicine 1993 Nov;72(6):393-406.
  33. Telomere shortening exposes functions for the mouse Werner and Bloom syndrome genes. Mol Cell Biol 2004 Oct;24(19):8437-8446.
  34. The Bloom's syndrome gene product is homologous to RecQ helicases. Cell 1995 Nov 17;83(4):655-666.
  35. Bloom's syndrome. Dermatol Clin 1995 Jan;13(1):7-18.
  36. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/UCM435003.
  37. Susceptibility pathways in Fanconi's anemia and breast cancer. N Engl J Med 2010 May 20;362(20):1909-1919.
  38. Ethel Moustacchi. 2003 Oct.
  39. A new trisomic syndrome. Lancet 1960 Apr 9;1(7128):787-790.
  40. The Fanconi anemia DNA repair pathway: structural and functional insights into a complex disorder. Ann Rev Biophys 2014;43:257-278.
  41. Numerical chromosomal changes and risk of development of myelodysplastic syndrome-acute myeloid leukemia in patients with Fanconi anemia. Cancer Genet Cytogenet 2010 Dec;203(2):180-186.
  42. Hypoxia-reoxygenation induces premature senescence in FA bone marrow hematopoietic cells. Blood 2005 Jul 1;106(1):75-85.
  43. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the EBMT experience. Blood 2013 Dec 19;122(26):4279-4286.
  44. International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood 1989 Feb;73(2):391-396.
  45. FANCM connects the genome instability disorders Bloom's syndrome and Fanconi anemia. Mol Cell 2009 Dec;36(6):943-953.
  46. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 1969 Oct;71(4):747-752.
  47. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990 Nov 30;250(4985):1233-1238.
  48. Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet 2002 Apr;39(4):225-242.
  49. Genetic insights into familial tumors of the nervous system. Am J Med Genet C Semin Med Genet 2004 Aug 15;129(1):74-84.
  50. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 1994 Mar 1;54(5):1298-1304.
  51. Germline mutations in the TP53 gene. Cancer Surv 1995;25:101-124.
  52. Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 2003 Mar;21(3):313-320.
  53. Andrews’ diseases of the skin: clinical dermatology. 10th ed. Philadelphia (PA): Saunders; 2005.
  54. Genetic instabilities in human cancers. Nature 1998 Dec;396(6712):643-649.
  55. Photosensitivity, corneal scarring and developmental delay: Xeroderma Pigmentosum in a tropical country. Cases J 2008 Oct 20;1(1):254.
  56. DNA repair and mutagenesis. Washington (DC): ASM Press; 2006. p. 1118.
  57. DNA damage, DNA repair, and alcohol toxicity-a review. Alcohol Clin Exp Res 1997 Sep;21(6):1073-1082.
  58. Concepts in biology. 14th ed. New York (NY): McGraw-Hill; 2007. p. 173.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.